Proactiveinvestors USA & Canada Cardiol Therapeutics https://ca.proactiveinvestors.com Proactiveinvestors USA & Canada Cardiol Therapeutics RSS feed en Sun, 07 Mar 2021 10:21:38 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Cardiol Therapeutics submits application to uplist the Nasdaq Exchange https://ca.proactiveinvestors.com/companies/news/942905/cardiol-therapeutics-submits-application-to-uplist-the-nasdaq-exchange-942905.html Wed, 03 Mar 2021 19:13:00 -0500 https://ca.proactiveinvestors.com/companies/news/942905/cardiol-therapeutics-submits-application-to-uplist-the-nasdaq-exchange-942905.html Cardiol Therapeutics files application to list on the Nasdaq stock exchange https://ca.proactiveinvestors.com/companies/news/942732/cardiol-therapeutics-files-application-to-list-on-the-nasdaq-stock-exchange-942732.html Tue, 02 Mar 2021 15:15:00 -0500 https://ca.proactiveinvestors.com/companies/news/942732/cardiol-therapeutics-files-application-to-list-on-the-nasdaq-stock-exchange-942732.html Cardiol CEO sees bright future for pharmaceutically produced cannabidiol after blockbuster Jazz-GW Pharmaceutical deal https://ca.proactiveinvestors.com/companies/news/940482/cardiol-ceo-sees-bright-future-for-pharmaceutically-produced-cannabidiol-after-blockbuster-jazz-gw-pharmaceutical-deal-940482.html Fri, 05 Feb 2021 12:00:00 -0500 https://ca.proactiveinvestors.com/companies/news/940482/cardiol-ceo-sees-bright-future-for-pharmaceutically-produced-cannabidiol-after-blockbuster-jazz-gw-pharmaceutical-deal-940482.html Cardiol Therapeutics sees positives for company after GW Pharma and Jazz Pharma announcement https://ca.proactiveinvestors.com/companies/news/940368/cardiol-therapeutics-sees-positives-for-company-after-gw-pharma--and-jazz-pharma-announcement-940368.html Thu, 04 Feb 2021 00:45:00 -0500 https://ca.proactiveinvestors.com/companies/news/940368/cardiol-therapeutics-sees-positives-for-company-after-gw-pharma--and-jazz-pharma-announcement-940368.html Cardiol Therapeutics forms two new committees for its Phase II/III trial of CardiolRx in COVID-19 patients https://ca.proactiveinvestors.com/companies/news/939167/cardiol-therapeutics-forms-two-new-committees-for-its-phase-iiiii-trial-of-cardiolrx-in-covid-19-patients-939167.html Thu, 21 Jan 2021 15:58:00 -0500 https://ca.proactiveinvestors.com/companies/news/939167/cardiol-therapeutics-forms-two-new-committees-for-its-phase-iiiii-trial-of-cardiolrx-in-covid-19-patients-939167.html Cardiol Therapeutics completes Phase I trial of lead drug CardiolRx https://ca.proactiveinvestors.com/companies/news/937225/cardiol-therapeutics-completes-phase-i-trial-of-lead-drug-cardiolrx-937225.html Tue, 22 Dec 2020 19:19:00 -0500 https://ca.proactiveinvestors.com/companies/news/937225/cardiol-therapeutics-completes-phase-i-trial-of-lead-drug-cardiolrx-937225.html Cardiol Therapeutics chooses Worldwide Clinical Trial for their Phase II/III study of CardiolRx https://ca.proactiveinvestors.com/companies/news/936629/cardiol-therapeutics-chooses-worldwide-clinical-trial-for-their-phase-iiiii-study-of-cardiolrx-936629.html Tue, 15 Dec 2020 21:12:00 -0500 https://ca.proactiveinvestors.com/companies/news/936629/cardiol-therapeutics-chooses-worldwide-clinical-trial-for-their-phase-iiiii-study-of-cardiolrx-936629.html Cardiol Therapeutics selects Worldwide Clinical Trials as its CRO for Phase II/III study of CardiolRx https://ca.proactiveinvestors.com/companies/news/936600/cardiol-therapeutics-selects-worldwide-clinical-trials-as-its-cro-for-phase-iiiii-study-of-cardiolrx-936600.html Tue, 15 Dec 2020 16:15:00 -0500 https://ca.proactiveinvestors.com/companies/news/936600/cardiol-therapeutics-selects-worldwide-clinical-trials-as-its-cro-for-phase-iiiii-study-of-cardiolrx-936600.html Cardiol Therapeutics is commercializing its THC-free cannabidiol formulation to treat heart disease https://ca.proactiveinvestors.com/companies/news/932971/cardiol-therapeutics-is-commercializing-its-thc-free-cannabidiol-formulation-to-treat-heart-disease-932971.html Tue, 03 Nov 2020 11:30:00 -0500 https://ca.proactiveinvestors.com/companies/news/932971/cardiol-therapeutics-is-commercializing-its-thc-free-cannabidiol-formulation-to-treat-heart-disease-932971.html Cardiol Therapeutic’s Cortalex THC free CBD product now available at Medical Cannabis by Shoppers https://ca.proactiveinvestors.com/companies/news/932206/cardiol-therapeutics-cortalex-thc-free-cbd--product-now-available-at-medical-cannabis-by-shoppers-932206.html Thu, 22 Oct 2020 19:20:00 -0400 https://ca.proactiveinvestors.com/companies/news/932206/cardiol-therapeutics-cortalex-thc-free-cbd--product-now-available-at-medical-cannabis-by-shoppers-932206.html Cardiol Therapeutics releases THC-free CBD oil Cortalex through Shoppers Drug Mart’s online portal https://ca.proactiveinvestors.com/companies/news/931936/cardiol-therapeutics-releases-thc-free-cbd-oil-cortalex-through-shoppers-drug-marts-online-portal-931936.html Tue, 20 Oct 2020 15:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/931936/cardiol-therapeutics-releases-thc-free-cbd-oil-cortalex-through-shoppers-drug-marts-online-portal-931936.html Cardiol Therapeutics receives FDA approval for Phase 2/3 COVID-19 trial with CardiolRX https://ca.proactiveinvestors.com/companies/news/930041/cardiol-therapeutics-receives-fda-approval-for-phase-23-covid-19-trial-with-cardiolrx-930041.html Fri, 25 Sep 2020 18:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/930041/cardiol-therapeutics-receives-fda-approval-for-phase-23-covid-19-trial-with-cardiolrx-930041.html Cardiol gets FDA nod for IND application for Phase II/III COVID-19 trial of lead drug CardiolRx https://ca.proactiveinvestors.com/companies/news/930039/cardiol-gets-fda-nod-for-ind-application-for-phase-iiiii-covid-19-trial-of-lead-drug-cardiolrx-930039.html Fri, 25 Sep 2020 17:09:00 -0400 https://ca.proactiveinvestors.com/companies/news/930039/cardiol-gets-fda-nod-for-ind-application-for-phase-iiiii-covid-19-trial-of-lead-drug-cardiolrx-930039.html Cardiol Therapeutics starts Health Canada approved Phase 1 clinical study of CardiolRx https://ca.proactiveinvestors.com/companies/news/927845/cardiol-therapeutics-starts-health-canada-approved-phase-1-clinical-study-of-cardiolrx-927845.html Fri, 28 Aug 2020 20:17:00 -0400 https://ca.proactiveinvestors.com/companies/news/927845/cardiol-therapeutics-starts-health-canada-approved-phase-1-clinical-study-of-cardiolrx-927845.html Cardiol Therapeutics initiates Health Canada approved Phase 1 clinical study of lead drug CardiolRx https://ca.proactiveinvestors.com/companies/news/927625/cardiol-therapeutics-initiates-health-canada-approved-phase-1-clinical-study-of-lead-drug-cardiolrx-927625.html Wed, 26 Aug 2020 17:32:00 -0400 https://ca.proactiveinvestors.com/companies/news/927625/cardiol-therapeutics-initiates-health-canada-approved-phase-1-clinical-study-of-lead-drug-cardiolrx-927625.html Cardiol Therapeutics is advancing its proprietary pharmaceutical cannabidiol therapeutics program to treat life-threatening heart disease https://ca.proactiveinvestors.com/companies/news/925395/cardiol-therapeutics-is-advancing-its-proprietary-pharmaceutical-cannabidiol-therapeutics-program-to-treat-life-threatening-heart-disease-925395.html Thu, 30 Jul 2020 11:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/925395/cardiol-therapeutics-is-advancing-its-proprietary-pharmaceutical-cannabidiol-therapeutics-program-to-treat-life-threatening-heart-disease-925395.html Cardiol Therapeutics appoints financial markets expert Steven Grasso as business advisor https://ca.proactiveinvestors.com/companies/news/922985/cardiol-therapeutics-appoints-financial-markets-expert-steven-grasso-as-business-advisor-922985.html Mon, 29 Jun 2020 13:40:00 -0400 https://ca.proactiveinvestors.com/companies/news/922985/cardiol-therapeutics-appoints-financial-markets-expert-steven-grasso-as-business-advisor-922985.html Cardiol Therapeutics closes $17.25M offering to boost pharmaceutical CBD commercialization efforts https://ca.proactiveinvestors.com/companies/news/921188/cardiol-therapeutics-closes-1725m-offering-to-boost-pharmaceutical-cbd-commercialization-efforts-921188.html Thu, 04 Jun 2020 15:27:00 -0400 https://ca.proactiveinvestors.com/companies/news/921188/cardiol-therapeutics-closes-1725m-offering-to-boost-pharmaceutical-cbd-commercialization-efforts-921188.html Cardiol Therapeutics to raise $15 million to support CardiolRx commercialization https://ca.proactiveinvestors.com/companies/news/919624/cardiol-therapeutics-to-raise-15-million-to-support-cardiolrx-commercialization-919624.html Thu, 14 May 2020 14:34:00 -0400 https://ca.proactiveinvestors.com/companies/news/919624/cardiol-therapeutics-to-raise-15-million-to-support-cardiolrx-commercialization-919624.html Cardiol Therapeutics says its nanotechnology successfully delivers anti-fibrotic drugs to diseased heart https://ca.proactiveinvestors.com/companies/news/917197/cardiol-therapeutics-says-its-nanotechnology-successfully-delivers-anti-fibrotic-drugs-to-diseased-heart-917197.html Tue, 14 Apr 2020 13:45:00 -0400 https://ca.proactiveinvestors.com/companies/news/917197/cardiol-therapeutics-says-its-nanotechnology-successfully-delivers-anti-fibrotic-drugs-to-diseased-heart-917197.html Cardiol Therapeutics shares positive new study results supporting lead drug’s ability to protect against heart failure https://ca.proactiveinvestors.com/companies/news/916383/cardiol-therapeutics-shares-positive-new-study-results-supporting-lead-drugs-ability-to-protect-against-heart-failure-916383.html Wed, 01 Apr 2020 13:59:00 -0400 https://ca.proactiveinvestors.com/companies/news/916383/cardiol-therapeutics-shares-positive-new-study-results-supporting-lead-drugs-ability-to-protect-against-heart-failure-916383.html Cardiol Therapeutics expecting significant growth in 2020 with launch of its pharmaceutical cannabidiol formulation in Canada https://ca.proactiveinvestors.com/companies/news/915995/cardiol-therapeutics-expecting-significant-growth-in-2020-with-launch-of-its-pharmaceutical-cannabidiol-formulation-in-canada-915995.html Fri, 27 Mar 2020 13:00:00 -0400 https://ca.proactiveinvestors.com/companies/news/915995/cardiol-therapeutics-expecting-significant-growth-in-2020-with-launch-of-its-pharmaceutical-cannabidiol-formulation-in-canada-915995.html Cardiol Therapeutics signs supply agreement with Medical Cannabis by Shoppers https://ca.proactiveinvestors.com/companies/news/915256/cardiol-therapeutics-signs-supply-agreement-with-medical-cannabis-by-shoppers-915256.html Thu, 19 Mar 2020 14:27:00 -0400 https://ca.proactiveinvestors.com/companies/news/915256/cardiol-therapeutics-signs-supply-agreement-with-medical-cannabis-by-shoppers-915256.html Cardiol Therapeutics inks supplier agreement to offer pharmaceutical cannabidiol products to Shoppers Drug Mart subsidiary https://ca.proactiveinvestors.com/companies/news/915239/cardiol-therapeutics-inks-supplier-agreement-to-offer-pharmaceutical-cannabidiol-products-to-shoppers-drug-mart-subsidiary-915239.html Wed, 18 Mar 2020 18:16:00 -0400 https://ca.proactiveinvestors.com/companies/news/915239/cardiol-therapeutics-inks-supplier-agreement-to-offer-pharmaceutical-cannabidiol-products-to-shoppers-drug-mart-subsidiary-915239.html Cardiol Therapeutics receives go-ahead from Health Canada for phase 1 study of its cannabidiol formulation https://ca.proactiveinvestors.com/companies/news/914399/cardiol-therapeutics-receives-go-ahead-from-health-canada-for-phase-1-study-of-its-cannabidiol-formulation-914399.html Thu, 05 Mar 2020 17:38:00 -0500 https://ca.proactiveinvestors.com/companies/news/914399/cardiol-therapeutics-receives-go-ahead-from-health-canada-for-phase-1-study-of-its-cannabidiol-formulation-914399.html